TrialSite’s First Reader Survey—Overall Good Marks with Some Surprises

TrialSite’s First Reader Survey—Overall Good Marks with Some Surprises

TrialSite recently concluded its first comprehensive readership survey thanks to the participation of several hundred viewers. We are happy to report that Judith_brown was selected as the winner of the survey participation prize. Congratulations to Judith_brown!  

TrialSite has grown tremendously, now approaching nearly 2 million visitors per month. We went to a subscriber model to ensure a sustainable financial model that could scale up and provide independent, unbiased content. Thankfully, this approach precludes the advertising sales route, which doesn’t guarantee independence. TrialSite’s viewership covers a range of demographic cohorts and backgrounds, not to mention professions. The majority of those that responded (84%) were not directly employed in healthcare. We note that other surveys indicate extensive representation by health care providers, biopharmaceutical, and related sectors. TrialSite reports that on a daily basis, people employed by the following institutions visit the platform for news and information:

The Senate & House of RepresentativesU.S. Food and Drug Administration National Institutes of HealthEuropean Medicines AgencyWord Health Orga...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee